- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 668
GV-backed Apptimize docks at Airship
App testing optimisation platform Apptimize, which counted Alphabet unit GV as an investor, has been acquired by Airship for an undisclosed amount.
Aug 30, 2019Miami’s RedHawk plunders for $1.5m fund
Run by Miami University students, VC unit RedHawk Ventures will seek $1.5m for a new fund to back university-linked startups.
Aug 30, 2019Luma Health blooms with $16m
Texas Medical Center and Cisco Investments are among the investors that helped the healthcare servies platform take its overall funding to almost $26m.
Aug 29, 2019Luma Health blooms with $16m
Stanford-StartX Fund-backed healthcare servies platform Luma Health has taken its overall funding to almost $26m.
Aug 29, 2019Boston Microfluidics collects series A funding
Home blood-collection device supplier Boston Microfluidics has secured LabCorp as an investor in a $17.5m round that was led by Anzu Partners.
Aug 29, 2019Bestmile mobilises series B funding
Groupe ADP and Airbus Ventures both backed a $16.5m round that took the fleet management platform's overall funding to $35.5m.
Aug 29, 2019ThoughtSpot dots i's on $248m round
Capital One and HPE-backed Thoughtspot was valued just shy of $2bn in a round that increased the total raised by the data analysis software provider to more than $550m.
Aug 29, 2019UChicago meets Kin in $47m round
UChicago Startup Investment Program is among a group of backers that provided $47m to support the launch of a Florida-focused home insurance carrier, the first of Kin's subsidiaries to underwrite its own policies.
Aug 29, 2019Temenos banks on Kony in $559m acquisition
SoftBank and Telstra are both set to exit digital banking technology developer Kony in an acquisition by Temenos that comes after about $113m of funding.
Aug 29, 2019Kite lifts HifiBio to $67m series C
Kite Pharma and existing investor Legend Star both took part in the autoimmune disease and cancer drug developer's latest round, which follows $37.5m last year.
Aug 29, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


